Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia

Significant loss of muscle mass may occur in cachexia and sarcopenia, which are major causes of mortality and disability. Cachexia represents a complex multi-organ syndrome associated with cancer and chronic diseases. It is often characterized by body weight loss, inflammation, and muscle and adipos...

Full description

Bibliographic Details
Main Authors: Laura Yedigaryan, Martina Gatti, Vittoria Marini, Tullia Maraldi, Maurilio Sampaolesi
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/15/2293
_version_ 1797414406407061504
author Laura Yedigaryan
Martina Gatti
Vittoria Marini
Tullia Maraldi
Maurilio Sampaolesi
author_facet Laura Yedigaryan
Martina Gatti
Vittoria Marini
Tullia Maraldi
Maurilio Sampaolesi
author_sort Laura Yedigaryan
collection DOAJ
description Significant loss of muscle mass may occur in cachexia and sarcopenia, which are major causes of mortality and disability. Cachexia represents a complex multi-organ syndrome associated with cancer and chronic diseases. It is often characterized by body weight loss, inflammation, and muscle and adipose wasting. Progressive muscle loss is also a hallmark of healthy aging, which is emerging worldwide as a main demographic trend. A great challenge for the health care systems is the age-related decline in functionality which threatens the independence and quality of life of elderly people. This biological decline can also be associated with functional muscle loss, known as sarcopenia. Previous studies have shown that microRNAs (miRNAs) play pivotal roles in the development and progression of muscle wasting in both cachexia and sarcopenia. These small non-coding RNAs, often carried in extracellular vesicles, inhibit translation by targeting messenger RNAs, therefore representing potent epigenetic modulators. The molecular mechanisms behind cachexia and sarcopenia, including the expression of specific miRNAs, share common and distinctive trends. The aim of the present review is to compile recent evidence about shared and divergent epigenetic mechanisms, particularly focusing on miRNAs, between cachexia and sarcopenia to understand a facet in the underlying muscle wasting associated with these morbidities and disclose potential therapeutic interventions.
first_indexed 2024-03-09T05:32:36Z
format Article
id doaj.art-bd8c2569e5a24075ba08fb1ef6d0ccf6
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T05:32:36Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-bd8c2569e5a24075ba08fb1ef6d0ccf62023-12-03T12:31:56ZengMDPI AGCells2073-44092022-07-011115229310.3390/cells11152293Shared and Divergent Epigenetic Mechanisms in Cachexia and SarcopeniaLaura Yedigaryan0Martina Gatti1Vittoria Marini2Tullia Maraldi3Maurilio Sampaolesi4Translational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, 3000 Leuven, BelgiumDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyTranslational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, 3000 Leuven, BelgiumDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, ItalyTranslational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, 3000 Leuven, BelgiumSignificant loss of muscle mass may occur in cachexia and sarcopenia, which are major causes of mortality and disability. Cachexia represents a complex multi-organ syndrome associated with cancer and chronic diseases. It is often characterized by body weight loss, inflammation, and muscle and adipose wasting. Progressive muscle loss is also a hallmark of healthy aging, which is emerging worldwide as a main demographic trend. A great challenge for the health care systems is the age-related decline in functionality which threatens the independence and quality of life of elderly people. This biological decline can also be associated with functional muscle loss, known as sarcopenia. Previous studies have shown that microRNAs (miRNAs) play pivotal roles in the development and progression of muscle wasting in both cachexia and sarcopenia. These small non-coding RNAs, often carried in extracellular vesicles, inhibit translation by targeting messenger RNAs, therefore representing potent epigenetic modulators. The molecular mechanisms behind cachexia and sarcopenia, including the expression of specific miRNAs, share common and distinctive trends. The aim of the present review is to compile recent evidence about shared and divergent epigenetic mechanisms, particularly focusing on miRNAs, between cachexia and sarcopenia to understand a facet in the underlying muscle wasting associated with these morbidities and disclose potential therapeutic interventions.https://www.mdpi.com/2073-4409/11/15/2293cachexiasarcopeniaepigeneticsmiRNAsskeletal muscleextracellular vesicles
spellingShingle Laura Yedigaryan
Martina Gatti
Vittoria Marini
Tullia Maraldi
Maurilio Sampaolesi
Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia
Cells
cachexia
sarcopenia
epigenetics
miRNAs
skeletal muscle
extracellular vesicles
title Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia
title_full Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia
title_fullStr Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia
title_full_unstemmed Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia
title_short Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia
title_sort shared and divergent epigenetic mechanisms in cachexia and sarcopenia
topic cachexia
sarcopenia
epigenetics
miRNAs
skeletal muscle
extracellular vesicles
url https://www.mdpi.com/2073-4409/11/15/2293
work_keys_str_mv AT laurayedigaryan sharedanddivergentepigeneticmechanismsincachexiaandsarcopenia
AT martinagatti sharedanddivergentepigeneticmechanismsincachexiaandsarcopenia
AT vittoriamarini sharedanddivergentepigeneticmechanismsincachexiaandsarcopenia
AT tulliamaraldi sharedanddivergentepigeneticmechanismsincachexiaandsarcopenia
AT mauriliosampaolesi sharedanddivergentepigeneticmechanismsincachexiaandsarcopenia